| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |